STS trial for calciprotein particle transformation and vascular calcification in hemodialysis

Phase 2, open-label, single-arm trial of sodium thiosulfate in arterial calcification, sponsored by Radboud University Medical Center. Primary endpoints: Difference in pre- to post-dialysis change in T50 between non-dosed and STS-dosed sessions and Change in pre-dialysis T50 across control and STS sessions. Planned start Sep 2026; status: authorised.